{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:13:20Z","timestamp":1759191200638,"version":"3.44.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,29]]},"DOI":"10.7759\/cureus.93503","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:55:31Z","timestamp":1759164931000},"source":"Crossref","is-referenced-by-count":0,"title":["Antisynthetase Syndrome With Classic Features and Anti\u2011PL\u20117 Positivity: A Rare Immunologic Variant"],"prefix":"10.7759","author":[{"given":"Karen  S","family":"Arrazola-Mendoza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo E","family":"Gonz\u00e1lez-Ch\u00e1vez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"De la Pe\u00f1a-Camacho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Reyes-Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulises","family":"Gomez-Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00321-x","article-title":"Idiopathic inflammatory myopathies","volume":"7","author":"Lundberg IE","year":"2021","unstructured":"Lundberg IE, Fujimoto M, Vencovsky J, et al.. Idiopathic inflammatory myopathies. Nat Rev Dis Primers. 2021, 7:86. 10.1038\/s41572-021-00321-x","journal-title":"Nat Rev Dis Primers"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-023-01033-0","article-title":"Epidemiology of the idiopathic inflammatory myopathies","volume":"19","author":"Khoo T","year":"2023","unstructured":"Khoo T, Lilleker JB, Thong BY, Leclair V, Lamb JA, Chinoy H. Epidemiology of the idiopathic inflammatory myopathies. Nat Rev Rheumatol. 2023, 19:695-712. 10.1038\/s41584-023-01033-0","journal-title":"Nat Rev Rheumatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.5692\/clinicalneurol.cn-001383","article-title":"Antisynthetase myopathy (Article in Japanese)","volume":"60","author":"Suzuki S","year":"2020","unstructured":"Suzuki S. Antisynthetase myopathy (Article in Japanese). Rinsho Shinkeigaku. 2020, 60:175-80. 10.5692\/clinicalneurol.cn-001383","journal-title":"Rinsho Shinkeigaku"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13155","article-title":"Muscle pathology of antisynthetase syndrome according to antibody subtypes","volume":"33","author":"Tanboon J","year":"2023","unstructured":"Tanboon J, Inoue M, Hirakawa S, et al.. Muscle pathology of antisynthetase syndrome according to antibody subtypes. Brain Pathol. 2023, 33:e13155. 10.1111\/bpa.13155","journal-title":"Brain Pathol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/2397198320902667","article-title":"Antisynthetase syndrome: a distinct disease spectrum","volume":"5","author":"Huang K","year":"2020","unstructured":"Huang K, Aggarwal R. Antisynthetase syndrome: a distinct disease spectrum. J Scleroderma Relat Disord. 2020, 5:178-91. 10.1177\/2397198320902667","journal-title":"J Scleroderma Relat Disord"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.01.022","article-title":"Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review","volume":"13","author":"Mahler M","year":"2014","unstructured":"Mahler M, Miller FW, Fritzler MJ. Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review. Autoimmun Rev. 2014, 13:367-71. 10.1016\/j.autrev.2014.01.022","journal-title":"Autoimmun Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00104310","article-title":"Antisynthetase syndrome positive for anti-threonyl-tRNA synthetase (anti-PL7) antibodies","volume":"37","author":"Hervier B","year":"2011","unstructured":"Hervier B, Uzunhan Y, Hachulla E, et al.. Antisynthetase syndrome positive for anti-threonyl-tRNA synthetase (anti-PL7) antibodies. Eur Respir J. 2011, 37:714-7. 10.1183\/09031936.00104310","journal-title":"Eur Respir J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2020.101503","article-title":"Clinical manifestations and treatment of antisynthetase syndrome","volume":"34","author":"Marco JL","year":"2020","unstructured":"Marco JL, Collins BF. Clinical manifestations and treatment of antisynthetase syndrome. Best Pract Res Clin Rheumatol. 2020, 34:101503. 10.1016\/j.berh.2020.101503","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/art.43038","article-title":"Clinical characteristics of anti-synthetase syndrome: analysis from the classification criteria for anti-synthetase syndrome project","volume":"77","author":"Faghihi-Kashani S","year":"2025","unstructured":"Faghihi-Kashani S, Yoshida A, Bozan F, et al.. Clinical characteristics of anti-synthetase syndrome: analysis from the classification criteria for anti-synthetase syndrome project. Arthritis Rheumatol. 2025, 77:477-89. 10.1002\/art.43038","journal-title":"Arthritis Rheumatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/CPM.0000000000000171","article-title":"The diagnosis and treatment of antisynthetase syndrome","volume":"23","author":"Witt LJ","year":"2016","unstructured":"Witt LJ, Curran JJ, Strek ME. The diagnosis and treatment of antisynthetase syndrome. Clin Pulm Med. 2016, 23:218-26. 10.1097\/CPM.0000000000000171","journal-title":"Clin Pulm Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e318260977c","article-title":"Anti-PL-7 (anti-threonyl-tRNA synthetase) antisynthetase syndrome: clinical manifestations in a series of patients from a European multicenter study (EUMYONET) and review of the literature","volume":"91","author":"Labirua-Iturburu A","year":"2012","unstructured":"Labirua-Iturburu A, Selva-O'Callaghan A, Vincze M, et al.. Anti-PL-7 (anti-threonyl-tRNA synthetase) antisynthetase syndrome: clinical manifestations in a series of patients from a European multicenter study (EUMYONET) and review of the literature. Medicine (Baltimore). 2012, 91:206-11. 10.1097\/MD.0b013e318260977c","journal-title":"Medicine (Baltimore)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-225284","article-title":"Novel endotypes of antisynthetase syndrome identified independent of anti-aminoacyl transfer RNA synthetase antibody specificity that improve prognostic stratification","volume":"83","author":"Wu S","year":"2024","unstructured":"Wu S, Xiao X, Zhang Y, Zhang X, Wang G, Peng Q. Novel endotypes of antisynthetase syndrome identified independent of anti-aminoacyl transfer RNA synthetase antibody specificity that improve prognostic stratification. Ann Rheum Dis. 2024, 83:775-86. 10.1136\/ard-2023-225284","journal-title":"Ann Rheum Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30254-0","article-title":"Classification and management of adult inflammatory myopathies","volume":"17","author":"Selva-O'Callaghan A","year":"2018","unstructured":"Selva-O'Callaghan A, Pinal-Fernandez I, Trallero-Aragu\u00e1s E, Milisenda JC, Grau-Junyent JM, Mammen AL. Classification and management of adult inflammatory myopathies. Lancet Neurol. 2018, 17:816-28. 10.1016\/S1474-4422(18)30254-0","journal-title":"Lancet Neurol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2017.0934","article-title":"Skeletal muscle involvement in antisynthetase syndrome","volume":"74","author":"Noguchi E","year":"2017","unstructured":"Noguchi E, Uruha A, Suzuki S, et al.. Skeletal muscle involvement in antisynthetase syndrome. JAMA Neurol. 2017, 74:992-9. 10.1001\/jamaneurol.2017.0934","journal-title":"JAMA Neurol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/8xj0b9","article-title":"Defining anti-synthetase syndrome: a systematic literature review","volume":"40","author":"Zanframundo G","year":"2022","unstructured":"Zanframundo G, Faghihi-Kashani S, Scir\u00e8 CA, et al.. Defining anti-synthetase syndrome: a systematic literature review. Clin Exp Rheumatol. 2022, 40:309-19. 10.55563\/clinexprheumatol\/8xj0b9","journal-title":"Clin Exp Rheumatol"},{"key":"ref16","article-title":"S\u00edndrome antisintetasa","volume":"4","author":"De Luca D","year":"2012","unstructured":"De Luca D, Staiger H, Bazt\u00e1n MC, Enz P, Kowalczuk A, Galimberti R. S\u00edndrome antisintetasa. Rev Asoc Colomb Dermatol . 2012, 4:381-4.","journal-title":"Rev Asoc Colomb Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/393850-antisynthetase-syndrome-with-classic-features-and-antipl7-positivity-a-rare-immunologic-variant","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:55:32Z","timestamp":1759164932000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/393850-antisynthetase-syndrome-with-classic-features-and-antipl7-positivity-a-rare-immunologic-variant"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.93503","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,29]]}}}